Tenderfy

Next Generation Sequencing Testing (NGS)

Buyer
NHS Blood and Transplant
Published
2026-10-26
Deadline
Not provided
Sources
UK_FTS
Value
Not provided

Description

The description is in the source language.

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read